Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 7/20 | 0.50 |
| ▸ | GABRB1 | P18505 | 5/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | HTR2B | P41595 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.50 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5074474 | 0.79 | CRHBP (0.45) | GABRA1GABRB1GABRB2LMNAGABRG2 | |
| SCHEMBL159454 | 0.74 | GABRA1 (0.41) | GABRA1GABRB1GABRB2LMNAGABRG2 | |
| SCHEMBL6013934 | 0.74 | GABRA1 (0.41) | GABRA1GABRB1GABRB2LMNAGABRG2 | |
| SCHEMBL27928450 | 0.74 | GABRA1 (0.46) | GABRA1GABRB1GABRB2LMNAGABRG2 | |
| SCHEMBL6487833 | 0.73 | GABRA1 (0.39) | GABRA1GABRB1GABRB2LMNAGABRG2 | |
| SCHEMBL3608275 | 0.73 | GABRA1 (0.39) | GABRA1GABRB1GABRB2LMNAGABRG2 | |
| SCHEMBL11075023 | 0.73 | GABRA1 (0.43) | GABRA1GABRB1GABRB2LMNAGABRG2 | |
| SCHEMBL6007538 | 0.73 | GABRA1 (0.39) | GABRA1GABRB1GABRB2LMNAGABRG2 | |
| SCHEMBL28054360 | 0.72 | GABRA1 (0.50) | GABRA1GABRB1GABRB2LMNAGABRG2 | |
| SCHEMBL4632329 | 0.71 | GABRA1 (0.38) | GABRA1GABRB1GABRB2LMNAGABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2037872-A2 | COMPOSITIONS COMPRISING BETULONIC ACID | Valtion Teknillinen Tutkimuskeskus (FI) | 2009-03-25 | — | — | EP | claimed |
| EP-2024385-A1 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS | Valtion Teknillinen Tutkimuskeskus (FI) | 2009-02-18 | — | — | EP | claimed |
| EP-2024384-A1 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIPROTOZOAL AGENTS | Valtion Teknillinen Tutkimuskeskus (FI) | 2009-02-18 | — | — | EP | claimed |
| EP-2023730-A1 | BETULIN DERIVED COMPOUNDS AS ANTI-FEEDANTS FOR PLANT PESTS | Valtion Teknillinen Tutkimuskeskus (FI) | 2009-02-18 | — | — | EP | claimed |
| WO-2007141383-A9 | BETULIN DERIVED COMPOUNDS AS ANTI-FEEDANTS FOR PLANT PESTS | VALTION TEKNILLINEN (FI) | 2008-07-17 | — | — | WO | claimed |
| WO-2007141391-A1 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIPROTOZOAL AGENTS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2007-12-13 | — | — | WO | claimed |
| WO-2007141390-A1 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIVIRAL AGENTS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2007-12-13 | — | — | WO | claimed |
| WO-2007141392-A2 | COMPOSITIONS COMPRISING BETULONIC ACID | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2007-12-13 | — | — | WO | claimed |
| WO-2007141389-A1 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2007-12-13 | — | — | WO | claimed |
| WO-2007141383-A1 | BETULIN DERIVED COMPOUNDS AS ANTI-FEEDANTS FOR PLANT PESTS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2007-12-13 | — | — | WO | claimed |
| WO-2023182327-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, ORGANIC EL DISPLAY DEVICE, AND METHOD FOR PRODUCING CURED PRODUCT | 東レ株式会社 | 2023-09-28 | — | — | WO | disclosed |
| CN-115698854-A | Photosensitive resin composition, cured product, display device, semiconductor device, and method for producing cured product | 东丽株式会社 | 2023-02-03 | — | — | CN | disclosed |
| CN-114249652-A | Phenol derivative and application thereof in medicine | 天地恒一制药股份有限公司 | 2022-03-29 | — | — | CN | disclosed |
| EP-2697206-B1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | ATIR HOLDING S A (LU) | 2019-04-03 | — | — | EP | disclosed |
| CN-105418672-B | One kind is containing big empty complex for hindering [O, N, O] tridentate ligand titanium, zirconium of bis aryloxy and application thereof | 吉林大学 | 2018-06-15 | — | — | CN | disclosed |
| US-20050154024-A1 | Compounds useful in therapy | PFIZER INC | 2005-07-14 | — | — | US | disclosed |
| EP-0324431-B1 | NEW INDOLYLPIPERIDINE COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-03-25 | — | — | EP | disclosed |
| US-5017703-A | Antiallergens, antiinflammatory | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| US-4935432-A | ANTIALLERGENS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-06-19 | — | — | US | disclosed |
| EP-0324431-A1 | New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154024-A1 | Compounds useful in therapy | PTGER4, PTGER3, ALOX5 | GABRA1 235/4885GABRB1 239/4885GABRB2 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.